ReviewFrontiers in oncology2022
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Yan Peng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
478 papers cite itlatest 60 shown
this paperpooled itcites it